Schedule 13G ownership disclosure
Protagonist Therapeutics Inc
COMMON STOCK · CUSIP: 74366E102
Event date: 2025-06-30
- Filing-level shares
- 3,207,774.00
- Percent of class
- 5.2%
- STATE STREET CORPORATION
Shares: 3,207,774.00 · Class: 5.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000093751-25-000483
- Form type
- SCHEDULE 13G
- Filer
- Protagonist Therapeutics, Inc
- CIK
- CIK 1377121
- Filed
- Aug 11, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership